Suppression of peripheral NGF attenuates neuropathic pain induced by chronic constriction injury through the TAK1-MAPK/NF- κB signaling pathways

Anti-nerve growth factor (NGF) monoclonal antibodies (anti-NGF mAbs) have been reported to significantly attenuate pain, but the mechanism involved has not been fully elucidated, and the serious adverse events...

Source: Cell Communication and Signaling - April 20, 2020 Category: Molecular Biology Authors: Wen-Ling Dai, Bing Yan, Yi-Ni Bao, Ji-Fa Fan and Ji-Hua Liu Tags: Research Source Type: research